Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines. It offers cardiovascular, cerebrovascular, and skeletal muscular treatment; and antitumor and nutritional drugs. The company was founded on March 27, 2000 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company